The loss or functional inactivation of tumor suppressor genes appears
to be one of the most fundamental genetic mechanisms of tumorigenesis,
and rational insights into the signaling pathways of tumor suppressor
genes have emerged as a successful strategy of identifying novel drug
discovery targets downstream of the tumor suppressor protein itself,
Elucidation of novel pathways downstream of p53 have established a lin
k between this important tumor suppressor gene and the insulin-like gr
owth factor-1 receptor (IGF-1r), either via direct regulation of IGF-1
receptor levels, or modulation of IGFs via transactivation of the ins
ulin-like growth factor-binding protein 3 (IGF-BP3) gene, Binding of I
GF-BP3 to IGFs inhibits both their mitogenic and cell survival functio
ns, highlighting a novel pathway whereby p53 may regulate apoptosis in
tumor cells.